medigraphic.com
SPANISH

Cirugía Cardiaca en México

ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 2

<< Back Next >>

Cir Card Mex 2019; 4 (2)

Infrequent complication after Jurdham procedure: Thrombus formation on the left ventricular lead successfully treated

Ortega-Zhindón DB, Ramírez-Castañeda S, Hernández-Rodríguez GE, Flores-Calderón O
Full text How to cite this article

Language: English
References: 8
Page: 65-67
PDF size: 242.53 Kb.


Key words:

Atrial, thrombus, Cardiac resynchronization, Heart failure, Jurdham procedure.

ABSTRACT

Cardiac resynchronization is accepted and recommended in selected patients with heart failure. However, leads implantation carries risks to certain early and late complications. We present a 69-year-old man, with a history of cardiac resynchronization therapy 3 years ago by Jurdham procedure, having a thrombus formation in the left atrium, attached to the endocavitary device (left ventricular lead), a situation treated with the successful extraction and implantation of a new device in a directed manner.


REFERENCES

  1. Jaffe LM, Morin DP, Cardiac Resynchronization Therapy: History, Present Status,and Future Directions. Ochsner J 2014;14:596-607.

  2. Elencwajg B, López N, Cardinali E, Trainini J. Resincronización ventricular: nuevatécnica y dispositivo para el implante endocavitario de un catéter en el ventrículoizquierdo. Rev Argent Cardiol 2010;78:43-6. [Article in Spanish].

  3. Elencwajg B, López N, Cardinali E, et al. The Jurdham procedure: Endocardialleft ventricular lead insertion via a femoral transseptal sheath for cardiac resynchronizationtherapy pectoral device implantation. Heart Rhythm 2012;9: 1798-804.

  4. Kirkfeldt RE, Johansen JB, Nohr EA, Jørgensen OD, Nielsen JC. Complicationsafter cardiac implantable electronic device implantations: an analysis of a complete,nationwide cohort in Denmark. Eur Heart J Volume 2014;35:1186-94.

  5. Ortega-Zhindón DB, Salazar-Hernández I, Yépez-Ramos DP, Flores-Calderón O,Dajer-Fadel WL, Ramírez-Castañeda S. Perforación de aurícula derecha y aortaascendente secundario a catéter de ablación. Reporte de caso. Cir Card Mex 2017;2: 71-73. [Article in Spanish].

  6. Ortega-Zhindón DB, López-Echeverría WE, Ramírez-Castañeda S. Perforaciónde ventrículo derecho por cable de marcapaso temporal. Reporte de un caso. CirCard Mex 2019; 4: 16-18. [Article in Spanish].

  7. Freire D, Rivara A, Agorrody V. Dispositivos implantables en la insuficienciacardíaca con fracción de eyección reducida. Más de 30 años de demostrada eficaciaterapéutica. Rev Urug Cardiol 2018; 33: 29-42. [Article in Spanish].

  8. Aguilar JA, Summerson C. Transarterial permanent pacing of the left ventricle. Anunusual complication. Rev Mex Cardiol 2002; 13: 56-58.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cir Card Mex. 2019;4